A new partnership to improve TB treatments around the world

 

endTB aims to find shorter, less toxic and more effective treatments for ‘multidrug-resistant TB’ (MDR-TB) through:

  • access to new drugs
  • a clinical trial
  • advocacy at national and global levels.

Covering 15 countries, the project is a partnership between Partners In Health, Médecins Sans Frontières, Interactive Research & Development and financial partner UNITAID.

Watch the two-minute animation

 

You can contact us, or follow us on Twitter.

endTB clinical trial begins in first country, Georgia

TB doctor Irma Davitadze at work at the Regional Center of Infectious Pathology, AIDS and Tuberculosis in Batumi, a beach resort town on the Black Sea. MSF has worked here since 2014. (Daro Sulakauri)

 

6 March 2017

The endTB partnership announce the launch of their major clinical trial, which aims to revolutionize MDR-TB treatments.

Read more

Watch: MSF animation on endTB's clinical trial

Thumbnail

 

8 December 2016

Wondering what endTB’s clinical trial aims to achieve, exactly? Watch this MSF-produced video to find out more.

Read more

PIH MSF MSF UNITAID